Text Size:

Stage 3: Locally Advanced Prostate Cancer

Information about Stage 3 prostate cancer, treatment options, and support for patients dealing with locally advanced disease in New Zealand.

Stage 3 prostate cancer has a 5-year survival rate of approximately 80-90%.

About 26% of men diagnosed with prostate cancer in New Zealand fall into the high-risk group, which includes Stage 3.

In 2021, approximately 46% of men with high-risk prostate cancer in New Zealand received surgery as their primary treatment.

Stage 3 prostate cancer means the cancer has spread beyond the prostate but has not yet reached distant parts of the body. At this stage:

  • The cancer has extended beyond the outer layer of the prostate
  • It may have spread to the seminal vesicles (glands that help produce semen)
  • PSA levels are typically above 20 ng/mL
  • The Gleason score is usually 7-10

Stage 3 is considered "locally advanced" and typically falls into the "high-risk" category. In New Zealand, approximately 26% of men diagnosed with prostate cancer are classified as high-risk.

High-risk prostate cancer requires more aggressive treatment approaches than earlier stages, but still has good outcomes with proper treatment.

Explore Cancer Stages